You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Review: celecoxib is as effective as other NSAIDs and leads to fewer gastrointestinal adverse effects

https://doi.org/10.1136/ebm.8.2.51

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    (2002) BMJ 325, 619. Deeks JJ, Smith LA, Bradley MD.. Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials.. ;. :. –23.
    OpenUrlAbstract/FREE Full Text

    
 
 QUESTION: In patients with osteoarthritis (OA) or rheumatoid arthritis (RA), is celecoxib as effective as other non-steroidal anti-inflammatory drugs (NSAIDs)? Does celecoxib have greater gastrointestinal (GI) safety than NSAIDs?

    Data sources

    Studies were identified by searching 3 electronic databases and by obtaining manufacturers’ reports of industry sponsored randomised controlled trials (RCTs).

    Study selection

    Studies were selected if they were double blind RCTs that compared celecoxib at a licensed therapeutic dose for ≥12 weeks with placebo or another NSAID in patients with active RA or OA.

    Data extraction

    1 reviewer extracted data from the original company trial reports. Multiple celecoxib treatment arms were combined for trials that randomised to ≥1 dose.

    Main results

    9 RCTS (15 187 patients) were included. 5 RCTs included a …

    View Full Text

    Footnotes

    • For correspondence: Dr J J Deeks, Institute of Health Sciences, Headington, Oxford, UK. jon.deeks{at}cancer.org.uk

    • Sources of funding: Pfizer and Searle.